RxDoctor Payments Data

David Parrella, MD

Vascular Neurology · Nashville, TNNPI 1225233141

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Penumbra, Inc. at 49.6% of the total. Reporting peaked in 2023 at $3,100 and has fallen 92.1% since, to $244 in 2025.

$5,496in general payments, 2019–2025

Across 41 payments — averaging $134.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$3K
  • Medtronic$818
  • Imperative Care, Inc$492
  • Stryker$358
  • Phenox Inc.$355
  • Johnson & Johnson$287
  • plus $461 from 4 others
$8,244in research payments, 2019–2025

Across 7 payments — averaging $1177.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$8K

What the payments were for

  • Speaking & faculty fees$2,40044%
  • Food & beverage$3,09656%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.3$2,725
Medtronic(2 entities)15$818
Imperative Care, Inc7$492
Stryker5$358
Phenox Inc.2$355
Johnson & Johnson5$287
Balt USA, LLC1$173
Microvention, Inc.1$143
Amgen1$123
Qapel Medical Inc1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$29,970
Medicare patients
74
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →